Tag:
cervical cancer
Latest Headlines
Latest Headlines
'Hitchhiking' gold nanostars can sneak into cancer cells
Researchers at Northwestern University are touting some positive results for an inventive drug delivery method.
GAVI Alliance could be closer to HPV vax deal
GAVI could be nearing a price deal with vaccine rivals GlaxoSmithKline and Merck for HPV vaccines Gardasil and Cervarix in the developing world.
Inovio vaccine targets head and neck HPV subtypes
Inovio has created a SynCon DNA vaccine against HPV6 and HPV11, which, in a preclinical trial published in Human Vaccines & Immunotherapeutics, triggered a strong immune response in mice.
Study: Gardasil does not cause autoimmune disease
There have been anecdotal reports that Gardasil, Merck's ($MRK) human papillomavirus vaccine, causes autoimmune disease. A study of almost 200,000 women over two years may finally scotch this...
U.K. drops GSK HPV shot in favor of Gardasil
It's official: The U.K. will drop GlaxoSmithKline's ($GSK) HPV vaccine in favor of Merck's ($MRK) competing product Gardasil. The decision comes after health officials added genital warts into the
FDA OKs Gen-Probe HPV test
The FDA has given its blessing to Gen-Probe's ($GPRO) APTIMA HPV assay, an amplified nucleic acid test that detects 14 high-risk HPV types associated with cervical cancer and precancerous lesions.
Gardasil bests Cervarix in cost effectiveness battle
According to a study published on the British Medical Journal's website, Merck's ($MRK) and Sanofi's ($SNY) HPV vaccine Gardasil is more cost effective than GlaxoSmithKline's ($GSK) Cervarix. In the
Study: For HPV, two shots may be enough
A new study conducted by the National Cancer Institute has found that two doses of the HPV vaccine may be just as effective as the recommended three-dose schedule. The findings are important because
Roche to buy Germany's mtm for up to $184M
Roche has signed an agreement through which it will acquire Heidelberg, Germany-based mtm laboratories, which develops in vitro diagnostics focusing on the early detection and diagnosis of cervical
Patient education needed for HPV vaccines, cancer screenings
Gardasil and Cervarix both protect women against common types of HPV, but other, less common strains of the disease still present a threat of infection that could eventually lead to cancer. That why
